CIT-话题@MedSci

#CIT#

176篇内容 | 3574人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738526, encodeId=2bca1e3852677, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT2018：国产生物可降解支架对于冠脉单支病变患者安全有效，支架厚度薄，材料降解周期短, objectType=article, longId=133541, objectId=e422133541a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e422133541a1, replyNumber=0, likeNumber=69, createdTime=2018-10-02, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e422133541a1, moduleTitle=CIT2018：国产生物可降解支架对于冠脉单支病变患者安全有效，支架厚度薄，材料降解周期短, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e422133541a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738525, encodeId=16d21e38525d7, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT 2018：新时代、新征程：从心脏介入治疗到心血管病整体防控, objectType=article, longId=133393, objectId=82ec13339331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82ec13339331, replyNumber=0, likeNumber=137, createdTime=2018-07-26, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82ec13339331, moduleTitle=CIT 2018：新时代、新征程：从心脏介入治疗到心血管病整体防控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82ec13339331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738528, encodeId=eb331e385286c, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT 2018：FDA新药审批顾问：抗血小板治疗的传说与现实, objectType=article, longId=134386, objectId=af41134386ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af41134386ae, replyNumber=0, likeNumber=60, createdTime=2018-06-13, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af41134386ae, moduleTitle=CIT 2018：FDA新药审批顾问：抗血小板治疗的传说与现实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af41134386ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738540, encodeId=2e3f1e385408b, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Clin Gastroenterology H： Tofacitinib诱导疗法可在3天内减轻UC患者的症状, objectType=article, longId=157888, objectId=b0b215e8885a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0b215e8885a, replyNumber=0, likeNumber=59, createdTime=2019-07-21, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0b215e8885a, moduleTitle=Clin Gastroenterology H： Tofacitinib诱导疗法可在3天内减轻UC患者的症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0b215e8885a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738535, encodeId=d8ae1e385356a, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=大冢制药的guadecitabine未达到一线治疗AML的III期研究的主要终点, objectType=article, longId=145679, objectId=d3dd1456e979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3dd1456e979, replyNumber=0, likeNumber=71, createdTime=2018-11-23, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3dd1456e979, moduleTitle=大冢制药的guadecitabine未达到一线治疗AML的III期研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3dd1456e979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738532, encodeId=46b11e385324e, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, objectType=article, longId=140780, objectId=68e0140e800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e0140e800a, replyNumber=0, likeNumber=65, createdTime=2019-05-22, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e0140e800a, moduleTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68e0140e800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738533, encodeId=96ce1e385338e, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Lancet：Upadacitinib对传统合成缓解病情抗风湿药物效果不佳的类风湿性关节炎效果显著, objectType=article, longId=140811, objectId=c58614081148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c58614081148, replyNumber=0, likeNumber=55, createdTime=2019-04-05, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c58614081148, moduleTitle=Lancet：Upadacitinib对传统合成缓解病情抗风湿药物效果不佳的类风湿性关节炎效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c58614081148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738534, encodeId=468a1e38534c3, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Lancet：Baricitinib：治疗系统性红斑狼疮的潜在新药, objectType=article, longId=144986, objectId=3030144986ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3030144986ac, replyNumber=0, likeNumber=59, createdTime=2018-10-02, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3030144986ac, moduleTitle=Lancet：Baricitinib：治疗系统性红斑狼疮的潜在新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3030144986ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738527, encodeId=35e71e385277c, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT 2018:中国已完成千例“不开胸换瓣”手术，有2个国产瓣膜上市, objectType=article, longId=133542, objectId=844e133542d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=844e133542d0, replyNumber=0, likeNumber=79, createdTime=2018-05-03, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=844e133542d0, moduleTitle=CIT 2018:中国已完成千例“不开胸换瓣”手术，有2个国产瓣膜上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=844e133542d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738530, encodeId=367c1e385301b, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, objectType=article, longId=136587, objectId=884f13658e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=884f13658e71, replyNumber=0, likeNumber=64, createdTime=2019-02-20, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=884f13658e71, moduleTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=884f13658e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738536, encodeId=05761e38536f3, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=AAPS PharmSciTech：新型药物纳米纤维可有效控制牙周炎的进展, objectType=article, longId=149490, objectId=0ffa14949081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ffa14949081, replyNumber=0, likeNumber=61, createdTime=2019-01-06, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ffa14949081, moduleTitle=AAPS PharmSciTech：新型药物纳米纤维可有效控制牙周炎的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ffa14949081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738523, encodeId=2f2d1e38523d0, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Am J Gastroenterol：Ascites-Q（调查问卷）为评价肝硬化腹水患者自我报告症状缓解的更佳方法, objectType=article, longId=133084, objectId=5dbc133084b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dbc133084b8, replyNumber=0, likeNumber=57, createdTime=2018-11-22, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dbc133084b8, moduleTitle=Am J Gastroenterol：Ascites-Q（调查问卷）为评价肝硬化腹水患者自我报告症状缓解的更佳方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dbc133084b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738521, encodeId=60961e385212a, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Resuscitation：抗血小板治疗能否改善院外心脏骤停后患者结局？, objectType=article, longId=122517, objectId=b16612251ec8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b16612251ec8, replyNumber=0, likeNumber=96, createdTime=2018-09-05, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b16612251ec8, moduleTitle=Resuscitation：抗血小板治疗能否改善院外心脏骤停后患者结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b16612251ec8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738524, encodeId=6d3f1e38524dd, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT 2018：QFR在患者水平诊断精度荟萃分析结果首发, objectType=article, longId=133391, objectId=d7f6133391ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7f6133391ea, replyNumber=0, likeNumber=74, createdTime=2018-07-25, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7f6133391ea, moduleTitle=CIT 2018：QFR在患者水平诊断精度荟萃分析结果首发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7f6133391ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738529, encodeId=9a3a1e3852942, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=艾伯维关节炎新药upadacitinib抵达3期终点效果优于Humira, objectType=article, longId=134758, objectId=7a56134e586f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a56134e586f, replyNumber=0, likeNumber=90, createdTime=2019-01-05, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a56134e586f, moduleTitle=艾伯维关节炎新药upadacitinib抵达3期终点效果优于Humira, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a56134e586f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738514, encodeId=259c1e38514b8, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？, objectType=article, longId=100531, objectId=077010053178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077010053178, replyNumber=0, likeNumber=101, createdTime=2017-07-28, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077010053178, moduleTitle=CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=077010053178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738518, encodeId=59d61e3851882, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Lancet oncol：Guadecitabine（SCI-100）的不同剂量和用药时间用于首次治疗的急性髓性白血病老年患者的安全性和有效性。, objectType=article, longId=110853, objectId=827611085371, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=827611085371, replyNumber=0, likeNumber=91, createdTime=2017-12-14, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=827611085371, moduleTitle=Lancet oncol：Guadecitabine（SCI-100）的不同剂量和用药时间用于首次治疗的急性髓性白血病老年患者的安全性和有效性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=827611085371)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738517, encodeId=7e571e3851751, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Resuscitation：院内心脏骤停儿童：肾上腺素给药间隔多久为宜？, objectType=article, longId=110420, objectId=70b1110420e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70b1110420e6, replyNumber=0, likeNumber=76, createdTime=2017-12-06, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70b1110420e6, moduleTitle=Resuscitation：院内心脏骤停儿童：肾上腺素给药间隔多久为宜？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70b1110420e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738520, encodeId=cb6c1e3852046, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=A novel Ruthenium(II) polypyridyl complex induces cytotoxicity, cell cycle arrest, apoptosis and DNA, objectType=article, longId=117031, objectId=7bbf11e031f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bbf11e031f1, replyNumber=0, likeNumber=85, createdTime=2017-11-29, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bbf11e031f1, moduleTitle=A novel Ruthenium(II) polypyridyl complex induces cytotoxicity, cell cycle arrest, apoptosis and DNA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bbf11e031f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738515, encodeId=75081e385158f, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Medsci可以查询CiteScore啦！, objectType=article, longId=101774, objectId=9ddf101e7431, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ddf101e7431, replyNumber=0, likeNumber=105, createdTime=2017-07-11, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ddf101e7431, moduleTitle=Medsci可以查询CiteScore啦！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ddf101e7431)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CIT

2020-05-29

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT2018：国产生物可降解支架对于冠脉单支病变患者安全有效，支架厚度薄，材料降解周期短

2018-10-02

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT 2018：新时代、新征程：从心脏介入治疗到心血管病整体防控

2018-07-26

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT 2018：FDA新药审批顾问：抗血小板治疗的传说与现实

2018-06-13

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Clin Gastroenterology H： Tofacitinib诱导疗法可在3天内减轻UC患者的症状

2019-07-21

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

大冢制药的guadecitabine未达到一线治疗AML的III期研究的主要终点

2018-11-23

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状

2019-05-22

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Lancet：Upadacitinib对传统合成缓解病情抗风湿药物效果不佳的类风湿性关节炎效果显著

2019-04-05

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Lancet：Baricitinib：治疗系统性红斑狼疮的潜在新药

2018-10-02

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT 2018:中国已完成千例“不开胸换瓣”手术，有2个国产瓣膜上市

2018-05-03

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究

2019-02-20

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

AAPS PharmSciTech：新型药物纳米纤维可有效控制牙周炎的进展

2019-01-06

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Am J Gastroenterol：Ascites-Q（调查问卷）为评价肝硬化腹水患者自我报告症状缓解的更佳方法

2018-11-22

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Resuscitation：抗血小板治疗能否改善院外心脏骤停后患者结局？

2018-09-05

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT 2018：QFR在患者水平诊断精度荟萃分析结果首发

2018-07-25

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

艾伯维关节炎新药upadacitinib抵达3期终点效果优于Humira

2019-01-05

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？

2017-07-28

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Lancet oncol：Guadecitabine（SCI-100）的不同剂量和用药时间用于首次治疗的急性髓性白血病老年患者的安全性和有效性。

2017-12-14

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Resuscitation：院内心脏骤停儿童：肾上腺素给药间隔多久为宜？

2017-12-06

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

A novel Ruthenium(II) polypyridyl complex induces cytotoxicity, cell cycle arrest, apoptosis and DNA

2017-11-29

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Medsci可以查询CiteScore啦！

2017-07-11

科室
- - 订阅+
  - 更多科室
工具
服务